NCT04609241

Clinical Trial for the Safety and Efficacy of Murine CD79b CAR-T Therapy for Patients With Relapsed and/or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma

Study Summary

A study of CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma

Want to learn more about this trial?

Request More Info

CD79b CAR-T CellsDRUG

Each subject receive CD79b CAR-Tcells by intravenous infusion

Facility	City	State	Country
The First Affiliated Hospital, College of Medicine, Zhejiang University	Hangzhou	Zhejiang	China

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026